Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma
The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help it expand use of a top drug.
The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help it expand use of a top drug.
